We are live on
!
Find out more
AAP
Arax Advisory Partners Portfolio holdings
AUM
$3.54B
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$6.97B
AUM Growth
+$4.79B
(+220%)
Cap. Flow
+$6.91B
Cap. Flow
% of AUM
99.25%
Top 10 Holdings %
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,371
Increased
1,984
Reduced
143
Closed
794
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 100 ETF
OEF
|
+$2.43B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.24B |
| 3 |
DFAI
Dimensional International Core Equity Market ETF
DFAI
|
+$202M |
| 4 |
American Century Diversified Corporate Bond ETF
KORP
|
+$152M |
| 5 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$91.2M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$62.6M |
| 3 |
AXON
Axon Enterprise
AXON
|
+$58.1M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$46.5M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$44.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.48% |
| 2 | Financials | 8.05% |
| 3 | Industrials | 7.03% |
| 4 | Consumer Discretionary | 6.62% |
| 5 | Healthcare | 6.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VMEO
3126
DELISTED
Vimeo
VMEO
| $1.88K | ﹤0.01% |
+242
| New | +$1.19K |
|
|
AOMR
3127
Angel Oak Mortgage REIT
AOMR
$223M
| $1.87K | ﹤0.01% |
+200
| New | +$1.92K |
|
|
LEO
3128
BNY Mellon Strategic Municipals
LEO
$386M
| $1.87K | ﹤0.01% |
+299
| New | +$1.78K |
|
3129
Traeger
COOK
$174M
| $1.84K | ﹤0.01% |
+30
| New | +$2.3K |
|
3130
Payoneer
PAYO
$2.41B
| $1.83K | ﹤0.01% |
+302
| New | +$2.02K |
|
3131
Genesis Energy
GEL
$1.89B
| $1.82K | ﹤0.01% |
+109
| New | +$1.83K |
|
|
XOMA
3132
DELISTED
Xoma
XOMA
| $1.81K | ﹤0.01% |
+47
| New | +$1.46K |
|
3133
Health Catalyst
HCAT
$175M
| $1.8K | ﹤0.01% |
+631
| New | +$2.16K |
|
3134
Surgery Partners
SGRY
$2.02B
| $1.8K | ﹤0.01% |
+83
| New | +$1.85K |
|
3135
Electromed
ELMD
$346M
| $1.79K | ﹤0.01% |
+73
| New | +$1.55K |
|
3136
Eve Holding
EVEX
$930M
| $1.79K | ﹤0.01% |
+469
| New | +$2.5K |
|
3137
Cardiff Oncology
CRDF
$74.6M
| $1.77K | ﹤0.01% |
862
+558
| +184% | +$1.54K |
|
|
SBC
3138
SBC Medical Group
SBC
$311M
| $1.77K | ﹤0.01% |
+409
| New | +$1.84K |
|
|
NREF
3139
NexPoint Real Estate Finance
NREF
$319M
| $1.77K | ﹤0.01% |
+125
| New | +$1.8K |
|
3140
Fennec Pharmaceuticals
FENC
$370M
| $1.76K | ﹤0.01% |
+188
| New | +$1.63K |
|
3141
Corbus Pharmaceuticals
CRBP
$176M
| $1.76K | ﹤0.01% |
+139
| New | +$1.32K |
|
3142
1-800-Flowers.com
FLWS
$265M
| $1.73K | ﹤0.01% |
377
+208
| +123% | +$1.15K |
|
|
BRT
3143
BRT Apartments
BRT
$267M
| $1.72K | ﹤0.01% |
+110
| New | +$1.72K |
|
3144
Amer Sports
AS
$21.6B
| $1.72K | ﹤0.01% |
+49
| New | +$1.85K |
|
3145
Edgewise Therapeutics
EWTX
$4.82B
| $1.72K | ﹤0.01% |
106
+58
| +121% | +$823 |
|
3146
ReposiTrak
TRAK
$159M
| $1.72K | ﹤0.01% |
+116
| New | +$2.01K |
|
3147
InnovAge Holding
INNV
$1.46B
| $1.71K | ﹤0.01% |
+331
| New | +$1.34K |
|
3148
Cerence
CRNC
$412M
| $1.69K | ﹤0.01% |
+136
| New | +$1.39K |
|
3149
Trevi Therapeutics
TRVI
$2.66B
| $1.69K | ﹤0.01% |
+185
| New | +$1.39K |
|
3150
Ranpak Holdings
PACK
$464M
| $1.69K | ﹤0.01% |
+301
| New | +$1.32K |
|
Similar funds
TYCC
TH
BCP
WWA
VPC
BPS
TCM
DILIC
Arax Advisory Partners's Q3 2025 Portfolio in Review
As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,371 new positions and adding to 1,984 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.
- Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
- Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
- Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
- Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
- Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
- Arax Advisory Partners opened 1,371 new positions and closed 794 in Q3 2025.
- Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.
Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.